Medifast (MED) Tops Q2 EPS by 64c; Lowers Outlook
Tweet
Share
E-mail
Get Alerts MED Hot Sheet
Price: $12.63 +0.72%
EPS Growth %: -195.2%
Financial Fact:
Basic earnings per share: 0.51
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -195.2%
Financial Fact:
Basic earnings per share: 0.51
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Medifast (NYSE: MED) reported Q2 EPS of $3.87, $0.64 better than the analyst estimate of $3.23. Revenue for the quarter came in at $453.3 million versus the consensus estimate of $447.87 million.
GUIDANCE:
Medifast sees FY2022 EPS of $12.70-$14.10, versus the consensus of $15.38. Medifast sees FY2022 revenue of $1.58-1.66 billion, versus the consensus of $1.8 billion.
For earnings history and earnings-related data on Medifast (MED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Duluth Holdings Inc. (DLTH) Tops Q2 EPS by 49c
- BRP Inc. (DOO) Reports Q2 Loss of Cd$0.18
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
